ClinConnect ClinConnect Logo
Search / Trial NCT03886129

Cerebral Haemodynamics in Transient Ischaemic Attack

Launched by UNIVERSITY OF LEICESTER · Mar 20, 2019

Trial Information

Current as of August 11, 2025

Terminated

Keywords

ClinConnect Summary

Adequate brain blood flow is essential for brain survival and function. Brain blood flow is kept relatively constant by a process called cerebral autoregulation (CA). CA is impaired in various diseases including head injury, diabetes, Alzheimer's dementia, pre-eclampsia and stroke. In stroke, impaired CA is associated with early deterioration and the need for emergency surgery to relieve brain swelling. Impaired CA in stroke has also been shown to be related to stroke severity and functional outcomes.

A transient ischaemic attack (TIA), also known as a mini-stroke, is the same as a stroke,...

Gender

ALL

Eligibility criteria

  • INCLUSION CRITERIA:
  • HEALTHY CONTROLS:
  • Willing to participate
  • Capacity to consent to the study
  • Aged over 18 years
  • Able (in the Investigator's opinion) and willing to comply with all study requirements
  • Good understanding of written and verbal English
  • TIA PATIENTS:
  • Willing to participate
  • Capacity to consent to the study
  • Aged over 18 years
  • Able (in the Investigator's opinion) and willing to comply with all study requirements
  • A diagnosis of acute (≤7 days) TIA, made by a specialist in the TIA clinic at University Hospitals of Leicester NHS Trust that fulfils the 2009 American Heart Association definition of TIA
  • Good understanding of written and verbal English
  • EXCLUSION CRITERIA:
  • ALL PARTICIPANTS (HEALTHY CONTROLS AND TIA PATIENTS)
  • Unwilling to take part
  • Unable to consent
  • Aged under 18 years
  • Unable (in the Investigator's opinion) or unwilling to comply with any study requirements
  • Female participants who are pregnant, lactating or planning pregnancy during the course of the study
  • A diagnosis of atrial fibrillation
  • A diagnosis of severe heart failure (Ejection Fraction \<30%)
  • Severe respiratory disease
  • Inadequate bilateral transcranial Doppler windows (see section 8.3)
  • Carotid stenosis ≥70% (unilateral or bilateral)
  • Participant enrolled in an interventional research study.
  • Poor understanding of written and verbal English

About University Of Leicester

The University of Leicester is a leading research institution in the UK, renowned for its commitment to advancing scientific knowledge and improving healthcare through innovative clinical trials. The university fosters a collaborative environment that integrates diverse disciplines, enabling the development of cutting-edge research initiatives aimed at addressing pressing medical challenges. With a focus on ethical practices and patient-centered outcomes, the University of Leicester is dedicated to enhancing clinical research methodologies and contributing to the advancement of medical sciences, ultimately striving to translate research findings into tangible health benefits for communities.

Locations

Leicester, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Thompson G Robinson, MD

Principal Investigator

University of Leicester

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials